Ignite Creation Date:
2024-05-05 @ 4:42 PM
Last Modification Date:
2024-10-26 @ 9:23 AM
Study NCT ID:
NCT00293592
Status:
COMPLETED
Last Update Posted:
2015-04-21
First Post:
2006-02-16
Brief Title:
Dexamethasone for Cardiac Surgery Trial
Sponsor:
UMC Utrecht
Organization:
UMC Utrecht
Study Overview
Official Title:
Dexamethasone for Cardiac Surgery Trial
Status:
COMPLETED
Status Verified Date:
2015-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a multicenter randomized double-blind trial comparing clinical outcomes after the administration of high-dose dexamethasone versus placebo in patients undergoing heart surgery with the use of cardiopulmonary bypass The primary endpoint is the occurrence of major complications including all-cause mortality myocardial infarction stroke renal failure and prolonged mechanical ventilation in the first 30 days after surgery
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None